MetLife Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,569
| Closed | -$47.8K | – | 2400 |
|
|
2020
Q1 | $47.8K | Sell |
12,569
-29,130
| -70% | -$111K | ﹤0.01% | 2229 |
|
|
2019
Q4 | $212K | Hold |
41,699
| – | – | ﹤0.01% | 1948 |
|
|
2019
Q3 | $211K | Hold |
41,699
| – | – | ﹤0.01% | 1915 |
|
|
2019
Q2 | $257K | Buy |
41,699
+9,436
| +29% | +$58.2K | ﹤0.01% | 1884 |
|
|
2019
Q1 | $150K | Hold |
32,263
| – | – | ﹤0.01% | 2144 |
|
|
2018
Q4 | $136K | Hold |
32,263
| – | – | ﹤0.01% | 2134 |
|
|
2018
Q3 | $202K | Hold |
32,263
| – | – | ﹤0.01% | 2071 |
|
|
2018
Q2 | $259K | Hold |
32,263
| – | – | ﹤0.01% | 1791 |
|
|
2018
Q1 | $241K | Hold |
32,263
| – | – | ﹤0.01% | 1789 |
|
|
2017
Q4 | $192K | Buy |
+32,263
| New | +$192K | ﹤0.01% | 1952 |
|